SCHEMBL23551503

SCHEMBL23551503

CNc1ccc(N2CCC(O)(CC(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 7/20 0.39
▸ NPY2R P49146 2/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ LDHA P00338 1/20 0.38
▸ LDHB P07195 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23551479 0.91 L3MBTL1 (0.40) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL23551391 0.90 LMNA (0.41) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL31334108 0.85 MAPT (0.38) L3MBTL1NPC1RAB9AMAPTMEN1
SCHEMBL23551473 0.85 FFAR4 (0.41) L3MBTL1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL29744638 0.84 MAPT (0.38) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL29535010 0.84 MAPT (0.42) L3MBTL1KDM4ENPC1RAB9ALMNA
SCHEMBL23539031 0.84 MAPT (0.38) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL23538815 0.84 MAPT (0.42) L3MBTL1KDM4ENPC1RAB9ALMNA
SCHEMBL25122064 0.83 MAPT (0.39) L3MBTL1NPC1RAB9ASMN1; SMN2LMNA
Lithium SCHEMBL29946900 0.83 MAPT (0.41) L3MBTL1KDM4ENPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127561-A1 ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR C4 THERAPEUTICS, INC. (US) 2021-06-24 — — WO disclosed
Send feedback